Hypoglycaemia induction experiments
hypoglycaemia, Hypoglycaemia
HYPOGLYCAEMIA, HYPOGLYCAEMIA
Hypoglycaemia induction was carried out during weeks 3 (double dose) and 6 (triple dose) for icodec and on days 4 (double dose) and 11 (triple dose) for glargine U100 while at steady state. To initiate hypoglycaemia induction, participants should not have experienced hypoglycaemia (PG <3.9 mmol/l) within 24 h or have any relevant medical condition that could confound the outcomes or pose unacceptable risk to the participant. Hypoglycaemia induction (Fig. Hypoglycaemic response assessments were conducted at predefined PG levels during hypoglycaemia development and recovery (Fig. 